# Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer

> **NCT02424448** · — · COMPLETED · sponsor: **The Christie NHS Foundation Trust** · enrollment: 6 (actual)

## Conditions studied

- Metastatic Castration Resistant Prostate Cancer

## Interventions

- **PROCEDURE:** Biopsies, blood and urine samples

## Key facts

- **NCT ID:** NCT02424448
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02424448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02424448, "Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02424448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*